S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
An Unusual Way to Invest in Gold (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
An Unusual Way to Invest in Gold (Ad)
Recession risks are fading, business economists say, but political tensions pose threat to economy
FMC stock just set a new ceiling higher, 50% higher indeed
Obama’s 2024 Confession (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
An Unusual Way to Invest in Gold (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
An Unusual Way to Invest in Gold (Ad)
Recession risks are fading, business economists say, but political tensions pose threat to economy
FMC stock just set a new ceiling higher, 50% higher indeed
Obama’s 2024 Confession (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
An Unusual Way to Invest in Gold (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
An Unusual Way to Invest in Gold (Ad)
Recession risks are fading, business economists say, but political tensions pose threat to economy
FMC stock just set a new ceiling higher, 50% higher indeed
Obama’s 2024 Confession (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
An Unusual Way to Invest in Gold (Ad)
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
An Unusual Way to Invest in Gold (Ad)
Recession risks are fading, business economists say, but political tensions pose threat to economy
FMC stock just set a new ceiling higher, 50% higher indeed
Obama’s 2024 Confession (Ad)
Venezuela defends military buildup, accusing neighboring Guyana of granting illegal oil contracts
Stock market today: World shares mostly higher after S&P 500 tops 5,000
NASDAQ:LIPO

Lipella Pharmaceuticals (LIPO) Stock Price, News & Analysis

$1.00
0.00 (0.00%)
(As of 02/9/2024 08:56 PM ET)
Compare
Today's Range
$0.96
▼
$1.01
50-Day Range
$0.89
▼
$1.11
52-Week Range
$0.85
▼
$2.93
Volume
3,900 shs
Average Volume
13,396 shs
Market Capitalization
$6.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media

LIPO stock logo

About Lipella Pharmaceuticals Stock (NASDAQ:LIPO)

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.

LIPO Stock Price History

LIPO Stock News Headlines

February 9, 2024 | finance.yahoo.com
Lipella Pharmaceuticals Inc. (LIPO)
December 20, 2023 | finanznachrichten.de
Lipella Pharmaceuticals Inc.: Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished
February 12, 2024 | The Freeport Society (Ad)
Biden Out, _______ In?
A new poll shows that two-thirds of Democrats want Biden to drop out of the 2024 race. The truth will shock you. 
December 20, 2023 | finance.yahoo.com
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished
December 9, 2023 | morningstar.com
Lipella Pharmaceuticals Inc Ordinary Shares
November 10, 2023 | markets.businessinsider.com
Lipella Pharma: FDA Grants Orphan Designation For LP-310 To Treat Oral Graft-versus-Host Disease
November 10, 2023 | finance.yahoo.com
FDA Grants Orphan Designation for Lipella's LP-310 Drug Candidate for Oral Graft-versus-Host Disease
October 25, 2023 | finance.yahoo.com
Lipella Pharmaceuticals Announces Closing of $2 Million Private Placement Priced At-The-Market Under Nasdaq Rules
February 12, 2024 | The Freeport Society (Ad)
Obama’s 2024 Confession
Barack Obama’s confession about the 2024 election just leaked online… In short, he’s worried Biden “could very well lose.” But before you think that means Trump will win… You should see the evidence I’ve found about an election shock that could come as soon as August 19th.
October 24, 2023 | finance.yahoo.com
Lipella Pharmaceuticals Announces $2 Million Private Placement Priced At-The-Market Under Nasdaq Rules
October 23, 2023 | finance.yahoo.com
Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference
October 22, 2023 | msn.com
Lipella Pharmaceuticals stock more than doubles in 3 days as FDA approves IND for OLP treatment
October 20, 2023 | benzinga.com
What's Going On With Lipella Pharmaceuticals Stock?
October 20, 2023 | msn.com
Investors Remain Cautious Over Fed Moves, Setting Wall Street Up for Lower Open
October 20, 2023 | benzinga.com
Gold Rises Over 1%; Schlumberger Shares Fall After Q3 Results
October 20, 2023 | marketwatch.com
Lipella Pharmaceuticals Shares Soar on FDA Approval
October 20, 2023 | finance.yahoo.com
Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-310 for Oral Lichen Planus
October 4, 2023 | msn.com
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.39%
October 4, 2023 | msn.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.39%
September 21, 2023 | finance.yahoo.com
Lipella Pharmaceuticals' Phase 2a Clinical Study Results Published in the Journal of Urology and Nephrology
September 7, 2023 | investing.com
Lipella Pharmaceuticals Inc (LIPO)
June 13, 2023 | finance.yahoo.com
Lipella Pharmaceuticals: Addressing Significant Unmet Need for Cancer Survivors, Delivering Long Term Value for Shareholders
May 15, 2023 | finanznachrichten.de
Lipella Pharmaceuticals Inc.: Lipella Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update
May 15, 2023 | msn.com
Lipella reports Q1 results
May 15, 2023 | finance.yahoo.com
Lipella Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update
May 14, 2023 | finance.yahoo.com
Lipella Pharmaceuticals First Quarter 2023 Earnings: US$0.19 loss per share (vs US$0.19 loss in 1Q 2022)
May 1, 2023 | finance.yahoo.com
Lipella Pharmaceuticals Delivers Late-Breaking Presentation at the American Urological Association Annual Meeting
See More Headlines
Receive LIPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lipella Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/13/2023
Today
2/11/2024
Next Earnings (Estimated)
3/29/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LIPO
CUSIP
N/A
CIK
1347242
Web
lipella.com
Phone
412-901-0315
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-2,600,000.00
Net Margins
-894.78%
Pretax Margin
-894.78%
Return on Equity
-124.14%
Return on Assets
-101.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.87
Quick Ratio
4.87

Sales & Book Value

Annual Sales
$180,000.00
Price / Sales
33.61
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.81 per share
Price / Book
1.23

Miscellaneous

Outstanding Shares
6,050,000
Free Float
3,658,000
Market Cap
$6.05 million
Optionable
Not Optionable
Beta
1.36
The Best High-Yield Dividend Stocks for 2023 Cover
The Best High-Yield Dividend Stocks for 2023

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Dr. Jonathan Kaufman M.B.A. (Age 58)
    Ph.D., Co-Founder, Chairman, CEO, President, Secretary & Treasurer
    Comp: $183.3k
  • Dr. Michael B. Chancellor M.D. (Age 66)
    Co-Founder, Chief Medical Officer & Director
    Comp: $175k
  • Mr. Douglas Johnston CPA (Age 39)
    Chief Financial Officer
    Comp: $67.5k
  • Ms. Michele Gruber
    Director of Operations
  • Katie Johnston
    Controller

Key Competitors

View All Competitors














LIPO Stock Analysis - Frequently Asked Questions

How have LIPO shares performed in 2024?

Lipella Pharmaceuticals' stock was trading at $1.02 at the beginning of the year. Since then, LIPO shares have decreased by 2.0% and is now trading at $1.00.
View the best growth stocks for 2024 here.

When is Lipella Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our LIPO earnings forecast.

When did Lipella Pharmaceuticals IPO?

(LIPO) raised $7 million in an IPO on Tuesday, December 20th 2022. The company issued 1,217,391 shares at $5.75 per share.

How do I buy shares of Lipella Pharmaceuticals?

Shares of LIPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LIPO) was last updated on 2/12/2024 by MarketBeat.com Staff

My Account -